OLANZAPINE and ANXIETY

Overview

ANXIETY is the #10 most commonly reported adverse reaction for OLANZAPINE, manufactured by Eli Lilly and Company. There are 3,375 FDA adverse event reports linking OLANZAPINE to ANXIETY. This represents approximately 1.7% of all 204,278 adverse event reports for this drug.

OLANZAPINE has an overall safety score of 88 out of 100. Patients taking OLANZAPINE who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ANXIETY is a less commonly reported adverse event for OLANZAPINE, but still significant enough to appear in the safety profile.

Other Side Effects of OLANZAPINE

In addition to anxiety, the following adverse reactions have been reported for OLANZAPINE:

• DRUG INEFFECTIVE — 7,120 reports
• WEIGHT INCREASED — 6,720 reports
• OFF LABEL USE — 5,714 reports
• DIABETES MELLITUS — 5,388 reports
• DRUG INTERACTION — 4,048 reports
• TOXICITY TO VARIOUS AGENTS — 3,966 reports
• SOMNOLENCE — 3,836 reports
• NAUSEA — 3,830 reports
• FATIGUE — 3,425 reports
• OVERDOSE — 3,352 reports

Other Drugs Associated with ANXIETY

The following drugs have also been linked to anxiety in FDA adverse event reports:

Does OLANZAPINE cause ANXIETY?

ANXIETY has been reported as an adverse event in 3,375 FDA reports for OLANZAPINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ANXIETY with OLANZAPINE?

ANXIETY accounts for approximately 1.7% of all adverse event reports for OLANZAPINE, making it a notable side effect.

What should I do if I experience ANXIETY while taking OLANZAPINE?

If you experience anxiety while taking OLANZAPINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages